Traws Pharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Traws Pharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TRAW
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001130598
Board of directors
-
Iain D. Dukes · Director · Executive ChairmanSince 2024
-
Jack E. Stover · DirectorSince 2023
-
James J. Marino · DirectorSince 2023
-
Jerome Groopman · DirectorSince 2023
-
Luba Greenwood · DirectorSince 2024
-
Mary Teresa Shoemaker · DirectorSince 2023
-
Nikolay Savchuk · Director · Chief Operating OfficerSince 2024
-
Peter Atadja · DirectorSince 2023
-
Steven M. Fruchtman · Director · PRESIDENT, CHIEF EXECUTIVE OFFSince 2023
-
Trafford Clarke · DirectorSince 2023
-
Viren Mehta · DirectorSince 2023
-
Werner Cautreels · Director · Chief Executive OfficerSince 2024
Chief executives
Werner Cautreels
· Chief Executive Officer
Since April 2024
Steven M. Fruchtman
· PRESIDENT, CHIEF EXECUTIVE OFF
Until April 2024
· Former
Board connections
3 of this board's directors also sit on 4 other boards.
- via James J. Marino
- via Luba Greenwood
- via Iain D. Dukes
- via Iain D. Dukes
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2024 | Guerin Mark Patrick Officer (CFO) | Shares withheld for tax | −2,221 | $0.47 | $1,044 |
| Jun 10, 2024 | Guerin Mark Patrick Officer (CFO) | Option exercise | +5,500 | — | — |
| Apr 1, 2024 | Redfield Robert Officer (Acting Chief Medical Officer) | Grant or award | +97,500 | — | — |
| Apr 1, 2024 | Pauza Charles David Officer (Chief Science Officer Virology) | Grant or award | +97,500 | — | — |
| Apr 1, 2024 | Werner Cautreels Director, Officer (Chief Executive Officer) | Grant or award | +200,000 | — | — |
| Apr 1, 2024 | Nikolay Savchuk Director, Officer (Chief Operating Officer) | Grant or award | +66,687 | — | — |
| Apr 1, 2024 | Iain D. Dukes Director, Officer (Executive Chairman) | Grant or award | +66,687 | — | — |
| Apr 1, 2024 | Nikolay Savchuk Director, Officer (Chief Operating Officer) | Grant or award | +67,550 | — | — |
| Apr 1, 2024 | Iain D. Dukes Director, Officer (Executive Chairman) | Grant or award | +67,550 | — | — |
| Apr 1, 2024 | Nikolay Savchuk Director, Officer (Chief Operating Officer) | Grant or award | +885,532 | — | — |
| Apr 1, 2024 | Iain D. Dukes Director, Officer (Executive Chairman) | Grant or award | +1,645,100 | — | — |
| Apr 1, 2024 | Nikolay Savchuk Director, Officer (Chief Operating Officer) | Grant or award | +1,645,100 | — | — |
| Mar 14, 2024 | Guerin Mark Patrick Officer (CFO AND COO) | Shares withheld for tax | −2,591 | $0.90 | $2,332 |
| Mar 14, 2024 | Steven M. Fruchtman Director, Officer (PRESIDENT, CHIEF EXECUTIVE OFF) | Shares withheld for tax | −8,727 | $0.90 | $7,854 |
| Mar 13, 2024 | Guerin Mark Patrick Officer (CFO AND COO) | Option exercise | +8,666 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.